100 Participants Needed

Digital Health Coaching for Multiple Myeloma

KB
AB
JL
Overseen ByJennifer Loftis, DNP
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Pack Health
Must be taking: Proteasome inhibitors, Immunomodulatory drugs
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This study will evaluate the feasibility of a digital health coaching program for adults with relapsed or refractory multiple myeloma (R/R MM). One hundred adults with R/R MM will be enrolled at The University of Washington. Individuals who agree to take part in the study and sign an informed consent will be enrolled in a 3-month digital health coaching program. The program will provide weekly phone calls plus the delivery of learning materials to text or email. Questionnaires and data from a wrist-worn activity tracker will be collected. Outcomes include treatment and symptom experience, quality of life, financial burden, and how confident people feel to manage their health. Information about your condition and treatment will be collected, along with how often you use services like the emergency room, for care. This data will provide a better understanding of how a person experiences their R/R MM.

Will I have to stop taking my current medications?

The trial protocol does not specify whether you need to stop taking your current medications. It seems focused on digital health coaching rather than medication changes.

What data supports the effectiveness of the Digital Health Coaching Program for Multiple Myeloma?

Research shows that digital health strategies, like educational programs and wearable devices, can improve treatment adherence and quality of life for multiple myeloma patients. These tools help patients better understand their condition and manage their treatment, leading to better health outcomes.12345

Is digital health coaching using devices like Fitbit safe for humans?

Research shows that using devices like Fitbit for digital health coaching is generally safe for humans. Participants in various studies found these devices comfortable and easy to use, with no significant safety concerns reported.678910

How does digital health coaching differ from other treatments for multiple myeloma?

Digital health coaching for multiple myeloma is unique because it uses technology to provide personalized support and guidance, potentially improving patient outcomes by promoting healthy lifestyle changes and symptom management. Unlike traditional treatments, it focuses on integrating digital tools like mobile apps and wearable devices to enhance patient engagement and self-management.711121314

Research Team

RB

Rahul Banerjee, MD

Principal Investigator

University of Washington

Eligibility Criteria

Adults over 18 with relapsed or refractory multiple myeloma, who have undergone at least one prior treatment including a proteasome inhibitor or immunomodulatory drug. Not for those with less than 6 months to live, without smartphone access, insufficient English proficiency, or on conflicting R/R MM studies.

Inclusion Criteria

I have been diagnosed with multiple myeloma, and I may also have AL amyloidosis.
I am starting my second or later treatment for multiple myeloma and have previously been treated with a PI or IMiD.
I am 18 years old or older.

Exclusion Criteria

Concurrent enrollment on a therapeutic study in R/R MM that precludes simultaneous enrollment onto our non-therapeutic study
You have been in Pack Health digital health coaching before.
Physician-assessed lack of sufficient English proficiency
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Digital Health Coaching Program

Participants are enrolled in a 3-month digital health coaching program, receiving weekly phone calls and learning materials via text or email. They will also wear a Fitbit device to capture physical activity data.

12 weeks
Weekly phone calls

Follow-up

Participants are monitored for changes in treatment experience, quality of life, and other outcomes after the digital health coaching program.

4 weeks

Treatment Details

Interventions

  • Digital Health Coaching Program
  • Fitbit
Trial OverviewThe trial is testing a digital health coaching program that includes weekly phone calls and educational materials via text/email. Participants will also use a Fitbit to track activity levels. The focus is on the impact of this program on quality of life and healthcare management confidence.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Single Arm Cohort Receiving Digital Health CoachingExperimental Treatment2 Interventions
All study participants will be enrolled in a 3-month digital health coaching program. They will also receive a Fitbit device to be worn daily for the capture of physical activity data.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Pack Health

Lead Sponsor

Trials
6
Recruited
1,100+

University of Washington

Collaborator

Trials
1,858
Recruited
2,023,000+

GlaxoSmithKline

Industry Sponsor

Trials
4,834
Recruited
8,389,000+
Headquarters
London, UK
Known For
Vaccines & Medicines
Top Products
**Advair (salmeterol, fluticasone propionate)**, **Shingrix (shingles vaccine)**, **Augmentin (amoxicillin/clavulanate potassium)**, **Ventolin (salbutamol sulfate)
Dame Emma Walmsley profile image

Dame Emma Walmsley

GlaxoSmithKline

Chief Executive Officer since 2017

MA in Classics and Modern Languages from Oxford University

Dr. Hal Barron profile image

Dr. Hal Barron

GlaxoSmithKline

Chief Medical Officer since 2018

MD from Harvard Medical School

Findings from Research

Healthcare professionals play a crucial role in promoting patient access and adherence to digital therapeutics, as they can prescribe these interventions and monitor their use, which is essential for effective treatment.
To enhance the adoption of digital therapeutics, stakeholders should focus on educating healthcare professionals, simplifying prescription processes, and empowering patients, alongside implementing macro-level changes like better financial incentives and blended care models.
There's an app for that, but nobody's using it: Insights on improving patient access and adherence to digital therapeutics in Germany.Dahlhausen, F., Zinner, M., Bieske, L., et al.[2022]
A 12-week eHealth exercise program for people with multiple myeloma was found to be safe and feasible, with no serious adverse events reported and a high adherence rate of 90%.
Participants experienced significant improvements in quality of life and physical fitness, with 96% reporting the program as beneficial and 89% satisfied with the delivery through the HEAL-Me app.
Feasibility of a tailored and virtually supported home exercise program for people with multiple myeloma using a novel eHealth application.Purdy, GM., Venner, CP., Tandon, P., et al.[2022]
Multiple myeloma (MM) patients experience significant health-related quality of life (HRQoL) challenges, particularly at diagnosis and relapse, highlighting the need for effective monitoring of their condition.
Digital health technologies, such as telemedicine and mobile health, have the potential to improve health outcomes for MM patients, but face barriers like limited access for older patients and a lack of integration with existing healthcare systems.
Digital Health for Patients With Multiple Myeloma: An Unmet Need.Jagannath, S., Mikhael, J., Nadeem, O., et al.[2021]

References

There's an app for that, but nobody's using it: Insights on improving patient access and adherence to digital therapeutics in Germany. [2022]
Feasibility of a tailored and virtually supported home exercise program for people with multiple myeloma using a novel eHealth application. [2022]
Digital Health for Patients With Multiple Myeloma: An Unmet Need. [2021]
A Novel Digital Educational Strategy Improves Treatment Adherence and Quality of Life in Patients with Multiple Myeloma. [2023]
What Intervention Elements Drive Weight Loss in Blended-Care Behavior Change Interventions? A Real-World Data Analysis with 25,706 Patients. [2022]
Utilizing wearable technology to increase physical activity in future physicians: A randomized trial. [2022]
Mobile Health and Preventive Medicine. [2023]
Wearable activity monitors in oncology trials: Current use of an emerging technology. [2019]
Understanding the Effect of Adding Automated and Human Coaching to a Mobile Health Physical Activity App for Afghanistan and Iraq Veterans: Protocol for a Randomized Controlled Trial of the Stay Strong Intervention. [2020]
10.United Statespubmed.ncbi.nlm.nih.gov
Acceptability of Fitbit for physical activity tracking within clinical care among men with prostate cancer. [2022]
A Mobile Phone-Based Health Coaching Intervention for Weight Loss and Blood Pressure Reduction in a National Payer Population: A Retrospective Study. [2019]
12.United Statespubmed.ncbi.nlm.nih.gov
Use of consumer wearable devices to promote physical activity among breast, prostate, and colorectal cancer survivors: a review of health intervention studies. [2020]
Personalized Coaching via Texting for Behavior Change to Understand a Healthy Lifestyle Intervention in a Naturalistic Setting: Mixed Methods Study. [2023]
Individualized eHealth Support for Oncological Therapy Management. [2020]